Abstract: A process is described for the decomposition of N2O during nitric acid production by bringing the N2O-containg waste gas leaving the absorption column into contact with a catalyst which comprises at least one oxidic cobalt compound and at least one oxidic magnesium compound, under conditions which permit conversion of N2O to gaseous nitrogen and oxygen. The content of oxidic cobalt compounds is in the range from 0.1 to 50% by weight and the content of oxidic magnesium compounds is in the range from 50 to 99.9% by weight, based in each case on the total weight of the catalyst, and at least 30% of the Co atoms present in the catalyst are present in the trivalent state. The preparation of the catalyst involves dry mixing of the oxidic cobalt compounds and the oxidic magnesium compounds or of appropriate precursors which are converted into the oxidic compounds by heat treatment, and compacting the mix, with exclusion of water, so that the resultant catalyst has the desired envelope density.

Abstract: This invention relates generally to a stabilization mechanism for use in oxidation/reduction catalyst systems. It particularly relates to a ruthenium stabilization mechanism that enables the use of inexpensive metallic species within catalyst systems targeted for the elimination of toxic emissions such as carbon monoxide, hydrocarbons, and other volatile organics, and specifically nitrogen oxide species. Said stabilization mechanism includes the use of zirconium-oxides in an oxidation-reduction catalyst.

Abstract: A catalyst for purifying NOx is provided which efficiently decomposes and purify the NOx in an exhaust gas in an oxygen-excess atmosphere, excels in resistance to heat and in durability in a high temperature range under a high-temperature oxidizing atmosphere and in the presence of moisture and SOx, and manifests the catalytic activity over a wide range of temperature. It is a catalyst for purifying nitrogen oxides formed by coating (A) a catalytically active component comprising (A-a) iridium and (A-b) at least one element selected from the group consisting of the elements of Group IIIB and Group IVB in the Periodic Table of the Elements with (B) a refractory inorganic compound.

Abstract: Herein is disclosed an oxygen scavenging composition, comprising (i) an oxygen scavenging polymer comprising units having structure I: 1

Abstract: Disclosed is a thermal dye-transfer dye-image receiving element comprising:

Abstract: Described are herbicide compositions (including suspension concentrates, herbicide compositions prepared therefrom), and others that include imidazolinone acid, which can optionally and preferably also include an acidifying agent, and methods of making and using such compositions.

Abstract: The subject of the invention is a method of plant-protection treatment by leaf absorption, characterized in that it uses a composition comprising at least one plant-protection active ingredient and at least one modified oil, a composition comprising at least one plant-protection active ingredient, at least one modified vegetable oil and at least one unmodified vegetable oil as well as an alkoxylated vegetable oil containing x% of glycerol.

Abstract: An Hg- or Nd-based oxide superconductor comprises Ba as a constituent element and has a content of carbon as an impurity at a level of not greater than 2.0 atomic % whereby the oxide superconductor stably shows high superconducting characteristics without causing degradation with time. For its production, BaO, which has a reduced content of carbon impurity of 0.5% or below, is provided as a feed stock for Ba, and the starting materials are mixed and processed in a dry atmosphere wherein an amount of a carbon-containing gas is suppressed to a certain level, thereby obtaining the oxide superconductor.

Abstract: A composite substrate structure including a substrate, a layer of a crystalline metal oxide or crystalline metal oxynitride material upon the substrate, a layer of an oriented cubic oxide material having a rock-salt-like structure upon the crystalline metal oxide or crystalline metal oxynitride material layer is provided together with additional layers such as one or more layers of a buffer material upon the oriented cubic oxide material layer.

Abstract: A palladium hydride superconductor, PdyHx where yHx is 1Hx, 2Hx, or 3Hx, having a critical temperature Tc≧11K and stoichiometric ratio x≧1. The critical temperature is proportional to a power of the stoichiometric ratio, which is stable over periods exceeding 24 hours, temperature variations from 4K to 400K, and pressures down to 1 mbar. The palladium hydride is coated with a stabilizing material such as a metal, metal oxide, ceramic, or polymer that can bond to palladium. It can be made by electrochemically loading a palladium lattice with isotopic hydrogen in an electrolytic solution, by allowing isotopic hydrogen to diffuse into a palladium thin film in a pressure chamber, or by injecting isotopic hydrogen into a palladium thin film in a vacuum chamber. The stabilizing material can be electrochemically bonded to the surface of the palladium hydride, or deposited using chemical vapor deposition or molecular beam epitaxy.

Abstract: It is an object to provide a tuning circuit which has large fractional frequency band width, for example frequency band of the return loss of less than −10 dB. The tuning circuit is composed of a superconductor microstrip lines, a superconductor distributed tunnel junction elements, a signal input part and a signal output part. It comprises at least a superconductor microstrip line and at least two superconductor tunnel junction elements, wherein the microstrip line and the tunnel junction element are connected alternately. The microstrip line and the tunnel junction element are half-wavelength of an input signal at a center frequency. A quarter-wavelength impedance transformer is comprised between a signal input part and a half-wavelength tunnel junction which is nearest to the signal input part.

Abstract: Methods for drilling, running casing in, and/or cementing a borehole in a subterranean formation without significant loss of drilling fluid are disclosed, as well as compositions for use in such methods. The methods employ drilling fluids comprising fragile gels or having fragile gel behavior and providing superior oil mud rheology and overall performance. The fluids are especially advantageous for use in offshore wells because the fluids exhibit minimal differences between downhole equivalent circulating densities and surface densities notwithstanding differences in drilling or penetration rates. When an ester and isomerized olefin blend is used for the base of the fluids, the fluids make environmentally acceptable and regulatory compliant invert emulsion drilling fluids.

Abstract: Disclosed is a concentrate composition for crosslinking polysaccharide polymers hydrated in an aqueous liquid, and well servicing fluids, preferably fracturing fluids, prepared therewith. Preferred polysaccharide polymers are galactomannan gums or derivatives thereof, preferably hydroxypropylguar. The concentrate comprises an alkali metal formate solution, preferably potassium formate, a crosslinking agent for the polysaccharide polymer, preferably a sparingly soluble alkali metal or alkali metal alkaline earth metal borate, and a suspension agent, preferably a clay mineral selected from the group consisting of smectite clays, palygorskite clays, and mixtures thereof Exemplary clays are hectorite, sepiolite, and attapulgite. The concentrate may, optionally, contain a deflocculant and/or an anti-syneresis additive.

Abstract: The present invention provides a new composite material comprising a porous matrix made of metal, metal alloy or semiconducting material and hollow fullerene-like nanoparticles of a metal chalcogenide compound or mixture of such compounds. The composite material is characterized by having a porosity between about 10% and about 40%. The amount of the hallow nanoparticles in the composite material is 1-20 wt. %.

Abstract: A first sliding member of the present invention is made of a composition comprising 10-50% by weight of carbon fibers and 2-30% by weight of a thermoplastic elastomer, the balance being substantially a polyphenylene sulfide resin, at least in a sliding surface portion. A second sliding member of the present invention is made of a composition comprising 10-50% by weight of glass fibers and 2-30% by weight of a thermoplastic elastomer, the balance being substantially a polyphenylene sulfide resin, at least in a sliding surface portion.

Abstract: An oil composition for heat treatment of a gear which comprises mineral oil having a kinematic viscosity of 5 to 40 mm2/second at 100° C. as a base oil and, based on a total amount of the composition, 0.01 to 5% by weight of (a) a phosphoric acid ester compound and, where necessary, 0.5 to 10% by weight of (b) one compound selected from alkenylsuccinimide compounds, alkylsuccinimide compounds and addition products of boron with alkenylsuccinimide compounds or alkylsuccinimide compounds and 0.5 to 10% by weight of (c) at least one compound selected from salicylates, phenates and sulfonates of alkaline earth metals.

Abstract: The invention concerns a threaded component for a seizure-resistant tubular threaded joint wherein a lubricating substance is deposited in a thin film on at least the surface of the threads of the threading, said surface being treated to adsorb said lubricating substance. The lubricating substance consists of a homogeneous mixture of a) a thickening agent; b) a set of extreme-pressure additives physically and chemically compatible with the thickening agent and comprising at least an extreme-pressure additive with chemical action called chemical EP additive and capable of being used at Hertz pressures not less than 1000 Mpa's; c) an oil. The proportions of the constituents of the lubricating substance are selected such that said lubricating substance has a consistency capable of ensuring a self-induced and film-forming lubricating process. The invention also concerns a method for producing the thin film.

Abstract: The invention provides a fluorescent grease which enables monitoring of behaviors of the grease for elucidation of the mechanism of grease lubrication, and a rolling element bearing or a condition monitoring rolling element bearing, both charged with the fluorescent grease. The fluorescent grease contains, as its essential components, a base oil, a thickener agent, and a fluorescent substance.

Abstract: Disclosed are personal cleansing compositions, and corresponding methods of application, wherein the compositions comprise (A) a cleansing phase containing a cleansing surfactant and water; and (B) an active phase containing lipophilic carrier and preferably a skin active agent; wherein the cleansing and active phases are physically separated from one another by one or more packaging barriers, located in the same or separate packages. Preferred embodiments are further defined by selected lipophilic carrier rheologies, defined active phase particulates for improved skin feel, and selected chronic skin active agents for use in the active phase. These compositions and corresponding methods provide improved cosmetics, skin feel, and/or skin active efficacy.

Abstract: Particulate laundry detergent compositions, especially high bulk density powders and tablets, contain low levels of aloe vera or other herbal extract beneficial to the skin. The herbal extract is preferably present in the form of coloured, preferably, green, speckles having a 1% solution pH not exceeding 9. The detergent compositions preferably contain a mild surfactant system.

Abstract: A composition for removing a copper-compatible resist includes about 10% to about 30% by weight of an amine compound, about 10% to about 80% by weight of a glycolether compound, and about 10% to about 80% by weight of a polar solvent.

Abstract: A substrate surface cleaning liquid medium and a cleaning method using the cleaning liquid medium are capable of removing finely particulate contaminants more efficiently than conventional techniques from substrates for devices in the production of semiconductor devices, display devices, etc., which cleaning liquid medium contains the following ingredients (A), (B), (C), and (D), has a pH of 9 or higher, and a content of ingredient (C) of 0.

Abstract: A method and composition for removing organic coatings or residues from a substrate is provided, which composition includes an organic carrier of ethanolamines and non-ionic alkylphenol ethoxylate surfactants and mixtures thereof and potassium hydroxide and being free of water.

Abstract: The properties of a fungal lipolytic enzyme can be altered by substituting amino acid residues corresponding to certain specified amino acid residues in the T. lanuginosus lipase. The altered property may be, e.g., an increased thermostability, an altered pH dependence, or an altered substrate specificity.

Abstract: Bleach activator cogranulates of one or more ammonium nitrites and at least one further bleach activator obtained by spraying an aqueous solution of one or more ammonium nitrites onto the further bleach activator, granulating the resulting mixture and drying and sieving the moist granulate.

Abstract: The present invention relates to methods for using amine oxide monomer-containing polymeric suds enhancers (enhancers) to increase the suds and/or foam volume and suds and/or foam retention in suds-forming and/or foam-forming compositions comprising such amine oxide monomer-containing polymeric suds enhancers. Suitable suds-forming and/or foam-forming compositions comprise one or more amine oxide monomer-containing polymeric suds enhancers.

Abstract: An aqueous fabric care composition for use in the wash or rinse cycle of a washing machine for cleaning or softening of fabrics concomitant with providing improved benefits to treated fabrics relating to moisture absorption, fragrance deposition, soil removal, reduced wrinkling prior to ironing and better appearance after ironing, said composition comprising:

Abstract: The present invention relates to compounds, and laundry compositions comprising said compounds, which are capable of providing enhanced anti-wrinkle benefits to cellulosic fiber containing fabric, said compounds having the formula: 1

Abstract: An antibacterial liquid dish cleaning composition with desirable cleansing properties comprising a C8-18 ethoxylated alkyl ether sulfate, two anionic surfactant, a betaine surfactant, a citric or lactic acid, at least one polyethylene glycol, an antibacterial agent and water.

Abstract: The invention relates to flowable mixtures comprising isethionate in combination with polyethylene glycols and to their use in liquid products without a further heating or solubilization operation.

Abstract: The invention relates to tenside granules with an improved disintegration rate that are obtained by granulating nonionic tensides of the hydroxy mixed ether type in the presence of disintegrants and compacting the products obtained.

Abstract: A compound of formula 1

Abstract: Described are methods for identifying compounds useful for regulation of body weight and associated conditions. In particular, methods are disclosed for identification of compounds that preferentially bind to and/or activate peripheral melanocortin receptors and which minimize binding and/or activation of central melanocortin receptors.

Abstract: The present invention provides 4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, novel intermediates of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignancy; and metabolic bone disease, comprising inhibiting said bone loss or excessive cartilage or matrix degradation by administering to a patient in need thereof a compound of the present invention.

Abstract: The present invention relates to compositions and methods relating to MEK5 and its role in heart disease. This protein has now been identified as a target for therapeutic intervention due to its role molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy. In particular, inhibition of MEK5 activity will lead to decrease signalling of the pathways and reduce or eliminate the effects on sarcomere assembly, which in turn result or contribute to cardiac dysfunction. Also provided are transgenic animals and methods of screening for inhibitors of MEK5.

Abstract: The invention provides a method of identifying therapeutic compounds in a genetically defined setting. The method consists of contacting a cell indicative of a pathological condition from a diseased individual and a cell from a genetically related normal individual with a plurality of candidate therapeutic compounds under suitable assay conditions, and identifying a compound that preferentially alters a predetermined property of the cell from the diseased individual.

Abstract: The invention provides a method for inhibiting c-jun activation in mammalian or avian cells comprising contacting the cells with a substance that inhibits the activity of Janus family kinase 3 (JAK-3). The invention also provides a therapeutic method for preventing or treating a pathological condition in a mammal wherein c-jun activation is implicated and inhibition of its activation is desired comprising administering to a mammal in need of such therapy, an effective amount of a substance that inhibits the activity of JAK-3. Novel compounds that are JAK-3 inhibitors, as well as pharmaceutical compositions comprising the compounds are also provided.

Abstract: Compositions containing peptide(s) and electrolyte excretion promoter(s) characterized by comprising a peptide or a peptide mixture, which is obtained by digesting cow's milk-origin protein with a protease and has an activity of inhibiting angiotensin converting enzyme, and one or more electrolyte excretion promoters selected from among chitosan, alginic acid and salts thereof. Owing to the synergistic effects of the components, these compositions exert an excellent effect of inhibiting increase in blood pressure.

Abstract: A pharmaceutical composition and method for inducing or accelerating a healing process of a skin wound are described. The pharmaceutical composition contains, as an active ingredient, a therapeutically effective amount of an agent for either enhancing PKC production and/or enhancing PKC activation; and a pharmaceutically acceptable carrier. The method is effected by administering the composition to a wound.

Abstract: The present invention relates to insoluble compositions comprising a protein selected from the group consisting of insulin, insulin analogs, and proinsulins; a derivatized protein selected from the group consisting of derivatized insulin, derivatized insulin analog, and derivatized proinsulin; a complexing compound; a hexamer-stabilizing compound; and a divalent metal cation. Formulations of the insoluble composition are suitable for both parenteral and non-parenteral delivery for treating hyperglycemia and diabetes. Microcrystal forms of the insoluble precipitate are pharmaceutically analogous to the neutral protamine Hagedorn (NPH) insulin crystal form. Surprisingly, it has been discovered that suspension formulations of such insoluble compositions possess unique and controllable dissolution properties that provide therapeutically advantageous glucodynamics compared with insulin NPH formulations.

Abstract: There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor and lack native-pattern glycosylation.

Abstract: A new class of synthetic glycosulfopeptides (GSPs) which have one or more sulfated tyrosine residues and a glycan linked to the peptide, the glycan preferably including a sialyl Lewisx group or a sialyl Lewisa group. In a preferred version the GSPs have an O-glycan comprising a &bgr;1,6 linkage to a GalNAc. The present invention further contemplates in vitro methods of the synthesis of these GSPs without the use of the cells and methods of their use in vivo as powerful anti-inflammatory antithrombotic, or anti-metastatic compounds. The invention also contemplates a method of synthesizing oligosaccharides by cleaving the glycan from the GSP.

Abstract: Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens.

Abstract: The present invention discloses a family of cyclic peptide monomers and supramolecular cyclic peptide structures comprising chromophore residues which possess electronic and electro-optic properties for producing molecular scale electronic and photonic devices made from such materials. More particularly, this invention provides for cyclic peptide nanotube structures formed from a plurality of stacked cyclic peptides comprising chromophore residues that provide molecular scale electronic conductivity and non linear optical behavior.

Abstract: Novel backbone cyclized peptide analogs are formed by means of bridging groups attached via the alpha nitrogens of amino acid derivatives to provide novel non-peptidic linkages. Novel building units disclosed are N&agr;(&ohgr;-functionalized) amino acids constructed to include a spacer and a terminal functional group. One or more of these N&agr;(&ohgr;-functionalized) amino acids are incorporated into a peptide sequence, preferably during solid phase peptide synthesis. The reactive terminal functional groups are protected by specific protecting groups that can be selectively removed to effect either backbone-to-backbone or backbone-to-side chain cyclizations. The invention is specifically exemplified by backbone cyclized bradykinin antagonists having biological activity. Further embodiments of the invention are somatostatin analogs having one or two ring structures involving backbone cyclization.

Abstract: The present invention relates to OPG fusion protein compositions, methods of preparation of such compositions and uses thereof. More particularly, the present invention relates to a fusion protein comprising an OPG polypeptide and an immunoglobulin FC region.

Abstract: The present invention provides novel androgen regulated nucleic acid molecules. Related polypeptides and diagnostic methods also are provided.

Abstract: This invention provides VEGF-FSH compounds having increased serum half-lives relative to either native VEGF or FSH, in which both VEGF and FSH are biologically active. This invention also provides related compositions and methods for increasing fertility, egg production and spermatogenesis in a subject, as well as methods for increasing vascularization in a tissue, particularly in ovarian tissue.

Abstract: More than 30% of human malignancies harbor encogenic Ras. Both pro-apoptotic and anti-apoptotic pathways emanate from encogenic Ras with survival being dominant. Ras survival signaling is thought to be controlled by transcriptional and post-translational processes. The present invention shows that a repressor of cap-dependent translation initiation, 4E-BP1, selectively activates apoptosis in Ras-transformed fibroblasts and eliminates Ras-induced chemoresistance. These effects of 4E-BP1 are strictly dependent on its ability to sequester translation initiation factor eIF4E, thereby preventing its assembly into an active pre-initiation complex. These results suggest that translational control is critical for prevention of apoptosis and resistance to antitumor agents in Ras-transformed cells.

Abstract: The present invention provides novel polynucleotides encoding TRP-PLIK2 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of TRP-PLIK2 polypeptides, TRP-PLIK2b, TRP-PLIK2c, and TRP-PLIK2d, respectively. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel TRP-PLIK2, TRP-PLIK2b, TRP-PLIK2c, and TRP-PLIK2d polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.